Notice of Intent to Sole Source – Becton, Dickinson and Company NOI-CC-25-009064
Summary
AI-generated · Sep 04, 2025Procurement of BD Rhapsody reagents and related components to enable single-cell mRNA and ATAC-Seq library preparation in tandem using the BD Rhapsody Single-Cell Analysis system, for simultaneous multiomic analysis of open chromatin and transcriptomes in single cells. Required items include the BD Rhapsody HT Xpress Package, BD Rhapsody 8-Lane Cartridge, BD Rhapsody Tagmentation and Supplemental Reagents Kit, BD Rhapsody Multiomic ATAC-Seq Amplification Kit, and Rhapsody Scanner Upgrade Kit. Reagents must be high quality and compatible with the BD Rhapsody system; BD Biosciences is the sole vendor capable of providing the necessary compatible reagents.
This action will be conducted as a sole-source procurement under FAR Part 13 Simplified Acquisition Procedures (Subpart 13.106-1(b)(1)), because only one source is reasonably available. No solicitation or quotations will be issued. Interested parties may express interest or capabilities in response to this posting; the government reserves discretion to determine whether to compete. Comments should reference this posting number and be submitted to the contracting activity by the specified deadline.
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for BD Rhapsody HT Xpress Package, BD Rhapsody 8-Lane Cartridge, BD Rhapsody Tagmentation and Supplemental Reagents Kit, BD Rhapsody Multiomic ATAC-Seq Amplification Kit and Rhapsody Scanner Upgrade Kit. These kits provide the necessary reagents for the preparation of single cell mRNA and ATAC-Seq libraries simultaneously with the BD Rhapsody Single-Cell Analysis system to generate multiomic analysis of open chromatin accessibility and transcriptome of single cells in one experiment. BD Biosciences is the only vendor that provides high quality reagents and compatible with its (BD) Rhapsody single-cell analysis system that we have in the lab. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.
From Special Notice posted on Sep 02, 2025Notice history
1Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA